With its stock down 18% over the past three months, it is easy to disregard Wuxi HyatechLtd (SHSE:688510). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Specifically, we decided to study Wuxi HyatechLtd’s ROE in this article.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Put another way, it reveals the company’s success at turning shareholder investments into profits.
See our latest analysis for Wuxi HyatechLtd
How To Calculate Return On Equity?
Return on equity can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity
So, based on the above formula, the ROE for Wuxi HyatechLtd is:
11% = CN¥120m ÷ CN¥1.1b (Based on the trailing twelve months to June 2024).
The ‘return’ is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each CN¥1 of shareholders’ capital it has, the company made CN¥0.11 in profit.
What Has ROE Got To Do With Earnings Growth?
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or “retains”, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don’t necessarily bear these characteristics.
Wuxi HyatechLtd’s Earnings Growth And 11% ROE
To start with, Wuxi HyatechLtd’s ROE looks acceptable. Especially when compared to the industry average of 4.8% the company’s ROE looks pretty impressive. This probably laid the ground for Wuxi HyatechLtd’s significant 22% net income growth seen over the past five years. However, there could also be other causes behind this growth. For instance, the company has a low payout ratio or is being managed efficiently.
We then compared Wuxi HyatechLtd’s net income growth with the industry and we’re pleased to see that the company’s growth figure is higher when compared with the industry which has a growth rate of 11% in the same 5-year period.
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock’s future looks promising or ominous. Is Wuxi HyatechLtd fairly valued compared to other companies? These 3 valuation measures might help you decide.
Is Wuxi HyatechLtd Making Efficient Use Of Its Profits?
Wuxi HyatechLtd has very a high three-year median payout ratio of 108% suggesting that the company’s shareholders are getting paid from more than just the company’s earnings. Despite this, the company’s earnings grew significantly as we saw above. Although, it could be worth keeping an eye on the high payout ratio as that’s a huge risk. You can see the 2 risks we have identified for Wuxi HyatechLtd by visiting our risks dashboard for free on our platform here.
While Wuxi HyatechLtd has seen growth in its earnings, it only recently started to pay a dividend. It is most likely that the company decided to impress new and existing shareholders with a dividend.
Summary
In total, it does look like Wuxi HyatechLtd has some positive aspects to its business. Namely, its high earnings growth, which was likely due to its high ROE. However, investors could have benefitted even more from the high ROE, had the company been reinvesting more of its earnings. As discussed earlier, the company is retaining hardly any of its profits. With that said, the latest industry analyst forecasts reveal that the company’s earnings are expected to accelerate. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
Valuation is complex, but we’re here to simplify it.
Discover if Wuxi HyatechLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
